A Study of Experimental Drug Crovalimab in Atypical Hemolytic Uremic Syndrome
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- Links
- Sign up for this study
- ID
- NCT04861259
- Phase
- Phase 3 Hemolytic-Uremic Syndrome Research Study
- Study Type
- Interventional
- Participants
- About 83 people participating
- Last Updated